Skip to main content

How to measure fractional area change of the RV

RV function by Echocardiography

Measurement of Fractional Area Change (FAC) of the Right Ventricle


Introduction

Assessment of right ventricular (RV) systolic function is an essential component of echocardiography, as RV dysfunction carries important diagnostic and prognostic implications in many cardiovascular diseases. Fractional Area Change (FAC) is a simple, reproducible, and guideline-recommended echocardiographic parameter used to quantify global RV systolic function.


What is Right Ventricular Fractional Area Change (RV FAC)?

RV FAC is a two-dimensional echocardiographic measurement that represents the percentage change in RV cavity area between end-diastole and end-systole. It reflects longitudinal and radial contraction of the RV and correlates reasonably well with RV ejection fraction measured by cardiac MRI.


Formula for RV FAC

RV FAC (%) =

[(RV End-Diastolic Area − RV End-Systolic Area) ÷ RV End-Diastolic Area] × 100


Echocardiographic View Required

• RV-focused apical four-chamber view

• The RV should be centered and maximized in the sector

• Avoid foreshortening of the RV apex

• The interventricular septum should be vertical


Step-by-Step Method of Measurement


1. Image Acquisition

• Obtain a high-quality RV-focused apical four-chamber view

• Optimize gain, depth, and sector width

• Freeze the image at true end-diastole (frame at onset of QRS or largest RV area)

• Freeze the image at true end-systole (smallest RV cavity area)



2. Endocardial Tracing

• Trace the RV endocardial border manually

• Include the RV free wall, apex, and interventricular septum

• Exclude trabeculations and papillary muscles from the cavity area

• Exclude the right atrium and the RV outflow tract



3. Area Calculation

• The machine automatically calculates RV end-diastolic area (RVEDA)

• Trace again at end-systole to obtain RV end-systolic area (RVESA)



4. FAC Calculation

• FAC is calculated automatically or manually using the standard formula




Normal Values and Interpretation


• Normal RV FAC: ≥ 35%

• Mild RV systolic dysfunction: 30–34%

• Moderate RV systolic dysfunction: 25–29%

• Severe RV systolic dysfunction: < 25%


Clinical Significance of RV FAC


RV FAC is clinically useful in:

• Pulmonary hypertension

• Right ventricular myocardial infarction

• Heart failure (HFrEF and HFpEF)

• Valvular heart disease (especially tricuspid regurgitation)

• Congenital heart disease

• Prognostic assessment in chronic lung disease and ARDS


A reduced RV FAC is associated with worse outcomes and increased mortality in several cardiovascular and pulmonary conditions.


Advantages of RV FAC


• Easy to measure

• Does not require Doppler alignment

• Reflects global RV systolic function

• Recommended by ASE and EACVI guidelines

• Useful when TAPSE is unreliable


Limitations of RV FAC


• Depends on image quality

• Limited in severe RV trabeculation

• Underestimates function in regional RV dysfunction

• Less accurate in markedly dilated or distorted RV geometry

• Two-dimensional measure of a complex three-dimensional structure


Comparison with Other RV Function Parameters


• TAPSE: Measures longitudinal RV function only

• S′ (Tissue Doppler): Angle-dependent

• RV FAC: Assesses global systolic function

• RV Strain: More sensitive but requires good image quality and software

• Cardiac MRI RVEF: Gold standard but less accessible


Guideline Recommendations


Current echocardiography guidelines recommend RV FAC as one of the core parameters for routine RV systolic function assessment, along with TAPSE, tissue Doppler S′ velocity, and RV strain when available. RV FAC should not be interpreted in isolation and must be correlated with clinical findings and other echocardiographic indices.


Practical Tips


• Always use RV-focused views

• Avoid foreshortening of the RV apex

• Measure multiple beats and average (especially in AF)

• Interpret FAC in conjunction with TAPSE and RV S′

• Ensure consistent end-diastolic and end-systolic frame selection


Conclusion


Right ventricular fractional area change is a robust, simple, and guideline-endorsed echocardiographic parameter for assessing RV systolic function. When performed correctly, it provides valuable diagnostic and prognostic information and should be part of every comprehensive echocardiographic examination.


For more cardiology infographics and educational articles visit:

drmusmanjaved.com



Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.